Christoph Menzel
Head, Companion Diagnostics & Biomarker Strategy The Healthcare Business of Merck KGaA, Darmstadt, Germany
Seminars
Tuesday 6th October 2026
Data-Powered CDx Development: A Case Study in Innovation
11:30 am
- Discover insights from Merck KGaA and Foundation Medicine’s innovative collaboration leveraging real-world evidence for CDx regulatory approval
- Explore how creative approaches to overcoming sample limitations enabled approval for a NSCLC CDx for TEPMETKO® (tepotinib)
- Learn how the right CDx partnership can reduce risk and accelerate patient access to therapy
